| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 423.11B | 404.01B | 370.14B | 339.90B | 317.60B | 309.69B |
| Gross Profit | 110.87B | 105.83B | 97.17B | 89.35B | 83.14B | 81.08B |
| EBITDA | 59.64B | 56.67B | 52.03B | 45.72B | 44.89B | 42.95B |
| Net Income | 30.52B | 26.97B | 25.25B | 20.20B | 20.49B | 16.64B |
Balance Sheet | ||||||
| Total Assets | 326.32B | 330.88B | 314.22B | 280.40B | 268.65B | 231.98B |
| Cash, Cash Equivalents and Short-Term Investments | 57.03B | 64.80B | 60.48B | 44.23B | 49.37B | 46.88B |
| Total Debt | 38.43B | 42.60B | 35.54B | 38.00B | 41.85B | 21.33B |
| Total Liabilities | 150.00B | 159.57B | 145.91B | 138.80B | 137.97B | 95.09B |
| Stockholders Equity | 174.28B | 169.05B | 166.42B | 139.89B | 128.92B | 112.27B |
Cash Flow | ||||||
| Free Cash Flow | 49.80B | 41.83B | 28.92B | 13.81B | 20.37B | 21.53B |
| Operating Cash Flow | 53.82B | 44.92B | 41.69B | 28.42B | 29.43B | 31.93B |
| Investing Cash Flow | -15.09B | -8.93B | -8.55B | -15.54B | -10.96B | -11.21B |
| Financing Cash Flow | -25.64B | -30.61B | -17.62B | -18.04B | -16.12B | -8.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥186.99B | 17.98 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥79.16B | 12.33 | ― | 3.28% | 5.28% | 28.90% | |
74 Outperform | ¥813.22B | 30.26 | 10.07% | 1.76% | 11.66% | -0.21% | |
72 Outperform | ¥71.33B | 15.99 | 14.67% | 2.91% | 10.02% | 16.48% | |
71 Outperform | ¥385.91B | 36.21 | ― | 0.22% | 25.00% | 62.07% | |
66 Neutral | ¥503.14B | 17.66 | ― | 2.17% | 10.42% | 28.75% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
BIPROGY Inc. has completed a share repurchase program authorized by its board in March 2025, acquiring a total of 1,703,900 shares of common stock for approximately 9.99 billion yen via market purchases on the Tokyo Stock Exchange between May 1, 2025, and January 8, 2026. The company will cancel all of these repurchased shares on March 25, 2026, reducing its total shares outstanding to 98,959,624, a move that tightens its capital base and is likely to enhance capital efficiency and shareholder value by decreasing share supply and potentially boosting earnings per share.
The most recent analyst rating on (JP:8056) stock is a Hold with a Yen5921.00 price target. To see the full list of analyst forecasts on BIPROGY Inc. stock, see the JP:8056 Stock Forecast page.
BIPROGY Inc. has reported the status of its ongoing share buyback program, conducted under the authorization of its articles of incorporation and the Companies Act of Japan. Between December 1 and December 31, 2025, the company repurchased 292,800 shares of its common stock on the Tokyo Stock Exchange for a total of ¥1,621,658,200, as part of a broader capital allocation policy aimed at enhancing shareholder value.
Under the board resolution passed on March 27, 2025, BIPROGY is authorized to buy back up to 2.5 million shares, or 2.5% of its outstanding shares excluding treasury stock, with a maximum budget of ¥10 billion between May 1, 2025, and February 27, 2026. As of December 31, 2025, the company has cumulatively repurchased 1,644,000 shares for ¥9,674,013,800, indicating the program is close to its authorized monetary limit and signaling a strong commitment to shareholder returns and capital efficiency.
The most recent analyst rating on (JP:8056) stock is a Hold with a Yen5921.00 price target. To see the full list of analyst forecasts on BIPROGY Inc. stock, see the JP:8056 Stock Forecast page.
BIPROGY Inc. announced the establishment of BCF1 Limited Partnership, a strategic fund aimed at fostering collaboration with startups and creating new business opportunities. With a maximum investment of 5 billion yen, the fund aligns with the company’s long-term goals under its ‘Vision 2030,’ advancing its position in the technology sector by embracing innovation and supporting sustainable growth.
The most recent analyst rating on (JP:8056) stock is a Hold with a Yen5921.00 price target. To see the full list of analyst forecasts on BIPROGY Inc. stock, see the JP:8056 Stock Forecast page.
BIPROGY Inc. has announced the absorption-type merger of its wholly owned subsidiary, Emellience Partners Inc., effective April 1, 2026. This merger aligns with the company’s management policies to streamline and expand its operations through strategic investments, leveraging Emellience Partners’ intellectual assets and capabilities. As part of the merger process, BIPROGY will waive 1.5 billion yen of Emellience Partners’ debt to eliminate its insolvency, a move aimed at optimizing growth and operational efficiency.
The most recent analyst rating on (JP:8056) stock is a Hold with a Yen5921.00 price target. To see the full list of analyst forecasts on BIPROGY Inc. stock, see the JP:8056 Stock Forecast page.
BIPROGY Inc. has announced its decision to acquire all shares of Yosemite 1 K.K., making it a subsidiary, to enhance its presence in the retail media market. This acquisition is expected to accelerate BIPROGY’s consumer and purchase-oriented solutions, leveraging CMJ’s extensive retail media network and BIPROGY’s technological assets to develop new services and expand globally, particularly in Asia.
The most recent analyst rating on (JP:8056) stock is a Buy with a Yen7300.00 price target. To see the full list of analyst forecasts on BIPROGY Inc. stock, see the JP:8056 Stock Forecast page.